For adult patients with secondary HPT on dialysis

Patient Assistance Programs

Patient Assistance Programs

This section reviews potential resources for patients who cannot afford the out-of-pocket cost for Sensipar®.

There is detailed information about key potential resources for qualifying patients including the Sensipar® Pharmacy Card*, Independent Co-pay Foundations for patients who may be subject to the donut hole, and the Safety Net Foundation.

Contact Amgen Assist® for more information on how to help your patients by calling 1-888-762-6436, or visit

* Patients receiving prescription reimbursement under Medicare (including Medicare Part D), Medicaid, or similar federal or state programs (including Veterans Affairs and TRICARE), and uninsured and/or self-paying patients are not eligible for the Sensipar® Pharmacy Card.

Go to Patient Assistance Programs

Patient Resources

Patients are able to download and print Sensipar® education materials. The available resources include:

Sensipar® Patient Brochure
Sensipar® Patient Brochure  |  Sensipar® Patient Brochure En Español
A complete review of "Why have I been prescribed Sensipar®?" and "How should I take Sensipar®?".
Sensipar® Patient Tearsheet
Sensipar® Patient Tearsheet  |  Sensipar® Patient Tearsheet En Español
A simple Sensipar® resource sheet that summarizes the most important information about Sensipar® so you can have a productive conversation with your patient when time is limited.

Online Resources

In addition, there are links to other helpful websites and patient organizations where you and your patients can learn more about secondary HPT and chronic kidney disease.

Go to Patient Resources

Test your knowledge

The two quizzes in this section are a great way to test your patient’s knowledge in a fun, interactive way while providing positive reinforcement.

Go to Quiz 1: Reviews concepts from Your Condition
Go to Quiz 2: Reviews concepts from About Sensipar®


Sensipar® (cinacalcet) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis.

Sensipar® should not be used in adult patients with CKD who are not on dialysis because of an increased risk of low calcium levels.

Important Safety Information

  • Sensipar® (cinacalcet) treatment should not be started if you have low calcium levels. Ask your doctor about the normal ranges. Life threatening events and fatal outcomes associated with low calcium levels have been reported in patients treated with Sensipar®, including in children.
  • Low calcium levels may potentially result in abnormal heart rhythms, known as ventricular arrhythmia, and have been reported in patients taking Sensipar®.
  • Before starting Sensipar®, tell your doctor if you are taking medication to prevent seizures or have had seizures in the past. Report any seizure episodes while on Sensipar® therapy.
  • Very infrequent cases of low blood pressure, worsening heart failure, and/or abnormal heart rhythm (arrhythmia) have been reported in patients with impaired heart function taking Sensipar®.
  • While on Sensipar®, your doctor should perform repeated blood tests to monitor calcium, phosphorus, and intact parathyroid hormone (iPTH) levels. Very low and very high levels of PTH should be avoided to help maintain bone health. Very low levels (iPTH < 100 pg/mL) of PTH may cause a condition your doctor may refer to as adynamic bone disease.
  • Patients with moderate to severe liver impairment should be monitored throughout treatment with Sensipar®.
  • Tell your doctor if you experience any muscle spasms, aches or cramping, tingling in your limbs, or seizures.
  • In clinical trials, the most common side effects reported in patients were nausea, vomiting, and diarrhea.

If you have any questions about this information, be sure to discuss them with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088 (332-1088).